Cangrelor dose titration using platelet function testing during cerebrovascular stent placement

BACKGROUND: Optimal antiplatelet inhibition is vital during cerebrovascular stenting procedures, yet no standardized recommendation exists for antithrombotic therapy in these scenarios. Cangrelor is an intravenous P2Y12 inhibitor with a favorable pharmacokinetic profile for use during neuroendovascu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Interv Neuroradiol
Main Authors: Entezami, Pouya, Holden, Devin N, Boulos, Alan S, Paul, Alexandra R, Field, Nicholas C, Nourollahzadeh, Emad, Yamamoto, Junichi, Dalfino, John C
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Ischemic Stroke
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903542/
https://ncbi.nlm.nih.gov/pubmed/32611215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1591019920936923
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados